Trials / Recruiting
RecruitingNCT05946057
Otoferlin Patient Registry and Natural History Study
Patient Registry for Individuals With Otoferlin-Associated Hearing Loss
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Tobias Moser · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This registry is designed to collect comprehensive information about the molecular genetic diagnoses of individuals with otoferlin-associated hearing impairment and clinical information to support a natural history study.
Detailed description
A patient registry, in both German and English languages, has been established for patients with hereditary hearing impairment due to variants in otoferlin (OTOF). The study is conducted in accordance with the current version of the Declaration of Helsinki. The study protocol and database structure have been approved by the Ethics Committee of the University Medical Center Göttingen. Main objective criterion: To increase understanding of natural history, types of genetic variants and to facilitate clinical and basic research on otoferlin-associated hearing impairment. Secondary objective criterion: To improve knowledge to better characterize individuals with otoferlin-associated hearing impairment in the long term and create prerequisites for improved, patient tailored therapy and care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Molecular genetic testing and audiometry | Genetic testing and audiometry are the interventions of interest |
Timeline
- Start date
- 2023-02-21
- Primary completion
- 2048-02-21
- Completion
- 2048-02-21
- First posted
- 2023-07-14
- Last updated
- 2025-05-28
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05946057. Inclusion in this directory is not an endorsement.